A Study of MHB046C Injection in Patients With Advanced Solid Tumors
Clinical trial NCT06985355 · RECRUITING
Trial details
- NCT number
- NCT06985355
- Sponsor
- Minghui Pharmaceutical (Hangzhou) Ltd
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-07-17
- Primary completion
- 2029-05-01
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.